These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6818533)

  • 1. New bacterial vaccines.
    Mäkelä PH
    Pediatr Infect Dis; 1982; 1(5):291-4. PubMed ID: 6818533
    [No Abstract]   [Full Text] [Related]  

  • 2. Conjugated polysaccharide vaccines.
    Ahmad H; Chapnick EK
    Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Emphasis on bacterial vaccines].
    Huet M
    Arch Inst Pasteur Tunis; 1982 Dec; 59(4):481-93. PubMed ID: 6820928
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsular polysaccharides as human vaccines.
    Jennings HJ
    Adv Carbohydr Chem Biochem; 1983; 41():155-208. PubMed ID: 6195893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

  • 7. Capsular polysaccharides as vaccine candidates.
    Jennings HJ
    Curr Top Microbiol Immunol; 1990; 150():97-127. PubMed ID: 2105188
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

  • 9. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
    Sood SK; Ballanco GA; Daum RS
    J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
    Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H
    Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
    Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
    J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Diagnostic value of the detection of specific polysaccharides by counterelectrophoresis in meningitis in children. 50 cases].
    Geslin P; Legrand P; Squinazi F; Brioude R; Leraillez J; Lejeune JA
    Nouv Presse Med; 1976 May; 5(22):1431-2. PubMed ID: 6946
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of new bacterial vaccines in children.
    Klein JO
    Isr J Med Sci; 1983 Nov; 19(11):1026-9. PubMed ID: 6420367
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumococcal vaccines.
    Lancet; 1978 Jan; 1(8056):131-2. PubMed ID: 87558
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic considerations for the development of conjugate vaccines.
    Garner CV; Pier GB
    Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971
    [No Abstract]   [Full Text] [Related]  

  • 17. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
    Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA
    Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis.
    Cripps AW; Foxwell R; Kyd J
    Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.